Abstract
- Population: 9-16 year-old seronegative individuals living in dengue endemic areas
- Intervention: 3 doses of CYD-TDV administered 6 months apart
- Comparison: Placebo
- Outcome: Virologically-confirmed dengue occurring > 12 months of completion of 3 doses
- GRADE table
- Dengue
